MIST Milestone Pharmaceuticals Inc.
Nasdaq · SEC CIK 1408443 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $1.18M 7 sales by 5 insiders
- Filings on record
- 89 since 2021-07-29, latest 2026-06-12 16:15
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Oliveto Joseph | Pres, CEO, Dir | — | $555.7K |
| Nelson Jeffrey Edward | COO | — | $158.2K |
| Bharucha David | Chief Medical Off | — | $158.2K |
| Hasija Amit | CFO, EVP of Corp. Development | — | $158.2K |
| Muller Lorenz | Chief Commercial Off | — | $145.9K |
Transactions 36
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-04-20 16:06 | 2026-04-16 | MIST | Oliveto Joseph | Pres, CEO, Dir | S - Sale | $2.26 | -36.5K | 446.2K | -8% | -$82.5K |
| DM | 2026-01-28 | 2025-12-15+ | MIST | Bharucha David | Chief Medical Off | S - Sale+OE | $2.25 | -70.3K | 105.3K | -40% | -$158.2K |
| D | 2026-01-28 | 2026-01-26 | MIST | Bharucha David | Chief Medical Off | M - OptEx | — | +20.1K | 125.4K | +19% | — |
| D | 2026-01-28 | 2025-12-12 | MIST | Bharucha David | Chief Medical Off | A - Grant | — | +100.0K | 163.3K | +158% | — |
| D | 2026-01-28 | 2025-12-12 | MIST | Muller Lorenz | Chief Commercial Off | A - Grant | — | +100.0K | 250.1K | +67% | — |
| DM | 2026-01-28 | 2025-12-15+ | MIST | Muller Lorenz | Chief Commercial Off | S - Sale+OE | $2.25 | -64.7K | 205.4K | -24% | -$145.9K |
| D | 2026-01-28 | 2026-01-26 | MIST | Muller Lorenz | Chief Commercial Off | M - OptEx | — | +20.1K | 216.6K | +10% | — |
| DM | 2026-01-28 | 2025-12-15+ | MIST | Hasija Amit | CFO, EVP of Corp. Development | S - Sale+OE | $2.25 | -70.3K | 92.0K | -43% | -$158.2K |
| D | 2026-01-28 | 2026-01-26 | MIST | Hasija Amit | CFO, EVP of Corp. Development | M - OptEx | — | +20.1K | 112.1K | +22% | — |
| D | 2026-01-28 | 2025-12-12 | MIST | Hasija Amit | CFO, EVP of Corp. Development | A - Grant | — | +100.0K | 150.0K | +200% | — |
| D | 2026-01-28 | 2026-01-26 | MIST | Nelson Jeffrey Edward | COO | M - OptEx | — | +20.1K | 62.1K | +48% | — |
| DM | 2026-01-28 | 2025-12-15+ | MIST | Nelson Jeffrey Edward | COO | S - Sale+OE | $2.25 | -70.3K | 49.8K | -58% | -$158.2K |
| D | 2026-01-28 | 2025-12-12 | MIST | Nelson Jeffrey Edward | COO | A - Grant | — | +100.0K | 100.0K | New | — |
| DM | 2026-01-28 | 2025-12-15+ | MIST | Oliveto Joseph | Pres, CEO, Dir | S - Sale+OE | $2.24 | -167.6K | 450.7K | -27% | -$375.3K |
| D | 2026-01-28 | 2026-01-26 | MIST | Oliveto Joseph | Pres, CEO, Dir | M - OptEx | — | +66.6K | 517.3K | +15% | — |
| D | 2026-01-28 | 2025-12-12 | MIST | Oliveto Joseph | Pres, CEO, Dir | A - Grant | — | +280.0K | 583.7K | +92% | — |
| M | 2026-01-09 | 2026-01-07+ | MIST | Oliveto Joseph | Pres, CEO, Dir | S - Sale | $2.25 | -43.5K | 303.7K | -13% | -$97.9K |
| 2025-12-11 | 2025-12-09 | MIST | Muller Lorenz | Chief Commercial Off | G - Gift | $0.00 | -25.0K | 150.1K | -14% | $0 | |
| D | 2025-07-15 | 2025-07-11 | MIST | Oliveto Joseph | Pres, CEO, Dir | A - Grant | — | +66.7K | 347.2K | +24% | — |
| D | 2025-07-15 | 2025-07-11 | MIST | Wills Robert James | Dir | A - Grant | — | +50.0K | 65.0K | +333% | — |
| D | 2025-07-15 | 2025-07-11 | MIST | Bharucha David | Chief Medical Off | A - Grant | — | +53.3K | 63.3K | +533% | — |
| D | 2025-07-15 | 2025-07-11 | MIST | Muller Lorenz | Chief Commercial Off | A - Grant | — | +66.7K | 175.1K | +62% | — |
| D | 2025-07-15 | 2025-07-11 | MIST | Hasija Amit | CFO, EVP of Corp. Development | A - Grant | — | +50.0K | 50.0K | New | — |
| D | 2025-07-15 | 2025-07-11 | MIST | PAPA JOSEPH C | Dir | A - Grant | — | +100.0K | 100.0K | New | — |
| D | 2025-07-15 | 2025-07-11 | MIST | Liebert Debra K. | Dir | A - Grant | — | +16.7K | 16.8K | +13,123% | — |
| I | 2023-03-24 | 2023-03-22 | MIST | WONG RODERICK | 10% | J - Other | — | -1.06M | 3.26M | -25% | — |
| M | 2022-12-05 | 2022-12-01+ | MIST | Bharucha David | Chief Medical Off | P - Purchase | $4.74 | +10.0K | 10.0K | New | +$47.4K |
| MI | 2022-10-21 | 2022-10-20+ | MIST | Liebert Debra K. | Dir | P - Purchase | $5.28 | +14.0K | 4,000 | New | +$73.9K |
| 2022-10-21 | 2022-10-19 | MIST | TOMSICEK MICHAEL JOHN | Dir | P - Purchase | $5.32 | +15.0K | 15.0K | New | +$79.8K | |
| 2022-10-21 | 2022-10-19 | MIST | Wills Robert James | Dir | P - Purchase | $4.93 | +15.0K | 15.0K | New | +$74.0K | |
| 2022-10-21 | 2022-10-20 | MIST | Pasternak Richard C | Dir | P - Purchase | $5.20 | +10.0K | 10.0K | New | +$52.0K | |
| 2022-09-15 | 2022-09-14 | MIST | Liebert Debra K. | Dir | J - Other | $0.00 | +127 | 127 | New | $0 | |
| I | 2022-09-09 | 2022-09-07 | MIST | RTW INVESTMENTS, LP | 10% | P - Purchase | $8.71 | +1.56M | 4.32M | +56% | +$13.56M |
| I | 2022-09-09 | 2022-09-07 | MIST | RTW INVESTMENTS, LP | 10% | S - Sale | $8.71 | -1.56M | 4.32M | -27% | -$13.56M |
| D | 2022-06-01 | 2022-05-31 | MIST | TRUEX PAUL F | Dir | P - Purchase | $5.60 | +5,000 | 81.8K | +7% | +$28.0K |
| DM | 2022-06-01 | 2022-05-31 | MIST | TRUEX PAUL F | Dir | M - OptEx | $1.51 | +76.8K | 8,016 | New | +$115.8K |
Purchase Sale Sale after option exercise All abbreviations